News from AHA 2024: CLEAR Outcomes PAD

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
AHA 2024 - Marc Bonaca presents the results of a sub-study from the CLEAR Outcomes trial on the effects of bempedoic acid on adverse limb event in statin-intolerant patients with symptomatic peripheral artery disease (PAD).
Educational information
This video was recorded during the AHA Scientific Sessions 2024 in Chicago, IL, US.
Faculty
Marc Bonaca, MD is a cardiologist and vascular medicine specialist and is the executive director of CPC Clinical Research and CPC Community Health at the University of Colorado, Boulder, CO, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 21 November 2024

Recommended

Details

Presenters

Overview
AHA 2024 - Marc Bonaca presents the results of a sub-study from the CLEAR Outcomes trial on the effects of bempedoic acid on adverse limb event in statin-intolerant patients with symptomatic peripheral artery disease (PAD).
Educational information
This video was recorded during the AHA Scientific Sessions 2024 in Chicago, IL, US.
Faculty
Marc Bonaca, MD is a cardiologist and vascular medicine specialist and is the executive director of CPC Clinical Research and CPC Community Health at the University of Colorado, Boulder, CO, US.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 21 November 2024

Bempedoic acid reduces adverse limb events in patients with PAD